AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
COMPARATIVE-ANALYSIS OF THE IN-VIVO EXPRESSION OF TYROSINASE, MART-1 MELAN-A, AND GP100 IN METASTATIC MELANOMA LESIONS - IMPLICATIONS FOR IMMUNOTHERAPY/
Authors: CORMIER JN ABATI A FETSCH P HIJAZI YM ROSENBERG SA MARINCOLA FM TOPALIAN SL
Citation: Jn. Cormier et al., COMPARATIVE-ANALYSIS OF THE IN-VIVO EXPRESSION OF TYROSINASE, MART-1 MELAN-A, AND GP100 IN METASTATIC MELANOMA LESIONS - IMPLICATIONS FOR IMMUNOTHERAPY/, Journal of immunotherapy, 21(1), 1998, pp. 27-31
IMMUNOLOGICAL AND THERAPEUTIC EVALUATION OF A SYNTHETIC PEPTIDE VACCINE FOR THE TREATMENT OF PATIENTS WITH METASTATIC MELANOMA
Authors: ROSENBERG SA YANG JC SCHWARTZENTRUBER DJ HWU P MARINCOLA FM TOPALIAN SL RESTIFO NP DUDLEY ME SCHWARZ SL SPIESS PJ WUNDERLICH JR PARKHURST MR KAWAKAMI Y SEIPP CA EINHORN JH WHITE DE
Citation: Sa. Rosenberg et al., IMMUNOLOGICAL AND THERAPEUTIC EVALUATION OF A SYNTHETIC PEPTIDE VACCINE FOR THE TREATMENT OF PATIENTS WITH METASTATIC MELANOMA, Nature medicine, 4(3), 1998, pp. 321-327
THE ROLE OF CD4(-CELL RESPONSES IN ANTITUMOR IMMUNITY() T)
Authors: PARDOLL DM TOPALIAN SL
Citation: Dm. Pardoll et Sl. Topalian, THE ROLE OF CD4(-CELL RESPONSES IN ANTITUMOR IMMUNITY() T), Current opinion in immunology, 10(5), 1998, pp. 588-594
RANDOMIZED PROSPECTIVE-STUDY OF THE BENEFIT OF ADJUVANT RADIATION-THERAPY IN THE TREATMENT OF SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Authors: YANG JC CHANG AE BAKER AR SINDELAR WF DANFORTH DN TOPALIAN SL DELANEY T GLATSTEIN E STEINBERG SM MERINO MJ ROSENBERG SA
Citation: Jc. Yang et al., RANDOMIZED PROSPECTIVE-STUDY OF THE BENEFIT OF ADJUVANT RADIATION-THERAPY IN THE TREATMENT OF SOFT-TISSUE SARCOMAS OF THE EXTREMITY, Journal of clinical oncology, 16(1), 1998, pp. 197-203
A BREAST AND MELANOMA-SHARED TUMOR-ANTIGEN - T-CELL RESPONSES TO ANTIGENIC PEPTIDES TRANSLATED FROM DIFFERENT OPEN READING FRAMES
Authors: WANG RF JOHNSTON SL ZENG G TOPALIAN SL SCHWARTZENTRUBER DJ ROSENBERG SA
Citation: Rf. Wang et al., A BREAST AND MELANOMA-SHARED TUMOR-ANTIGEN - T-CELL RESPONSES TO ANTIGENIC PEPTIDES TRANSLATED FROM DIFFERENT OPEN READING FRAMES, The Journal of immunology (1950), 161(7), 1998, pp. 3596-3606
GENERATION AND GENETIC-CHARACTERIZATION OF IMMORTAL HUMAN PROSTATE EPITHELIAL-CELL LINES DERIVED FROM PRIMARY-CANCER SPECIMENS
Authors: BRIGHT RK VOCKE CD EMMERTBUCK MR DURAY PH SOLOMON D FETSCH P RHIM JS LINEHAN WM TOPALIAN SL
Citation: Rk. Bright et al., GENERATION AND GENETIC-CHARACTERIZATION OF IMMORTAL HUMAN PROSTATE EPITHELIAL-CELL LINES DERIVED FROM PRIMARY-CANCER SPECIMENS, Cancer research, 57(5), 1997, pp. 995-1002
MELANOMA-SPECIFIC CD4(-CELLS RECOGNIZE NONMUTATED HLA-DR-RESTRICTED TYROSINASE EPITOPES() T)
Authors: TOPALIAN SL GONZALES MI PARKHURST M LI YF SOUTHWOOD S SETTE A ROSENBERG SA ROBBINS PF
Citation: Sl. Topalian et al., MELANOMA-SPECIFIC CD4(-CELLS RECOGNIZE NONMUTATED HLA-DR-RESTRICTED TYROSINASE EPITOPES() T), The Journal of experimental medicine, 183(5), 1996, pp. 1965-1971
ANALYSIS OF CYTOKINE SECRETION BY MELANOMA-SPECIFIC CD4-LYMPHOCYTES( T)
Authors: MARKUS NR ROSENBERG SA TOPALIAN SL
Citation: Nr. Markus et al., ANALYSIS OF CYTOKINE SECRETION BY MELANOMA-SPECIFIC CD4-LYMPHOCYTES( T), Journal of interferon & cytokine research, 15(8), 1995, pp. 739-746
CLONING OF A NEW GENE ENCODING AN ANTIGEN RECOGNIZED BY MELANOMA-SPECIFIC HLA-A24-RESTRICTED TUMOR-INFILTRATING LYMPHOCYTES
Authors: ROBBINS PF ELGAMIL M LI YF TOPALIAN SL RIVOLTINI L SAKAGUCHI K APPELLA E KAWAKAMI Y ROSENBERG SA
Citation: Pf. Robbins et al., CLONING OF A NEW GENE ENCODING AN ANTIGEN RECOGNIZED BY MELANOMA-SPECIFIC HLA-A24-RESTRICTED TUMOR-INFILTRATING LYMPHOCYTES, The Journal of immunology, 154(11), 1995, pp. 5944-5950
QUANTITATIVE CORRELATION BETWEEN HLA CLASS-I ALLELE EXPRESSION AND RECOGNITION OF MELANOMA-CELLS BY ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
Authors: RIVOLTINI L BARRACCHINI KC VIGGIANO V KAWAKAMI Y SMITH A MIXON A RESTIFO NP TOPALIAN SL SIMONIS TB ROSENBERG SA MARINCOLA FM
Citation: L. Rivoltini et al., QUANTITATIVE CORRELATION BETWEEN HLA CLASS-I ALLELE EXPRESSION AND RECOGNITION OF MELANOMA-CELLS BY ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES, Cancer research, 55(14), 1995, pp. 3149-3157
THE USE OF POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 (PEG-IL-2) IN THE TREATMENT OF PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA AND MELANOMA - A PHASE-I STUDY AND A RANDOMISED PROSPECTIVE STUDY COMPARING IL-2 ALONE VERSUS IL-2 COMBINED WITH PEG-IL-2
Authors: YANG JC TOPALIAN SL SCHWARTZENTRUBER DJ PARKINSON DR MARINCOLA FM WEBER JS SEIPP CA WHITE DE ROSENBERG SA
Citation: Jc. Yang et al., THE USE OF POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 (PEG-IL-2) IN THE TREATMENT OF PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA AND MELANOMA - A PHASE-I STUDY AND A RANDOMISED PROSPECTIVE STUDY COMPARING IL-2 ALONE VERSUS IL-2 COMBINED WITH PEG-IL-2, Cancer, 76(4), 1995, pp. 687-694
TREATMENT OF PATIENTS WITH METASTATIC MELANOMA WITH AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2
Authors: ROSENBERG SA YANNELLI JR YANG JC TOPALIAN SL SCHWARTZENTRUBER DJ WEBER JS PARKINSON DR SEIPP CA EINHORN JN WHITE DE
Citation: Sa. Rosenberg et al., TREATMENT OF PATIENTS WITH METASTATIC MELANOMA WITH AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2, Journal of the National Cancer Institute, 86(15), 1994, pp. 1159-1166
A PROSPECTIVE RANDOMIZED TRIAL EVALUATING COLLOID VERSUS CRYSTALLOID RESUSCITATION IN THE TREATMENT OF THE VASCULAR LEAK SYNDROME-ASSOCIATED INTERLEUKIN-2 THERAPY
Authors: POCKAJ BA YANG JC LOTZE MT LANGE JR SPENCER WF STEINBERG SM TOPALIAN SL SCHWARTZENTRUBER DJ WHITE DE ROSENBERG SA
Citation: Ba. Pockaj et al., A PROSPECTIVE RANDOMIZED TRIAL EVALUATING COLLOID VERSUS CRYSTALLOID RESUSCITATION IN THE TREATMENT OF THE VASCULAR LEAK SYNDROME-ASSOCIATED INTERLEUKIN-2 THERAPY, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 22-28
MHC CLASS-II RESTRICTED TUMOR-ANTIGENS AND THE ROLE OF CD4(-CELLS IN CANCER-IMMUNOTHERAPY() T)
Authors: TOPALIAN SL
Citation: Sl. Topalian, MHC CLASS-II RESTRICTED TUMOR-ANTIGENS AND THE ROLE OF CD4(-CELLS IN CANCER-IMMUNOTHERAPY() T), Current opinion in immunology, 6(5), 1994, pp. 741-745
RANDOMIZED COMPARISON OF HIGH-DOSE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 FOR THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA - AN INTERIM-REPORT
Authors: YANG JC TOPALIAN SL PARKINSON D SCHWARTZENTRUBER DJ WEBER JS ETTINGHAUSEN SE WHITE DE STEINBERG SM COLE DJ KIM HI LEVIN R GULERIA A MACFARLANE MP WHITE RL EINHORN JH SEIPP CA ROSENBERG SA
Citation: Jc. Yang et al., RANDOMIZED COMPARISON OF HIGH-DOSE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 FOR THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA - AN INTERIM-REPORT, Journal of clinical oncology, 12(8), 1994, pp. 1572-1576
IN-VITRO PREDICTORS OF THERAPEUTIC RESPONSE IN MELANOMA PATIENTS RECEIVING TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2
Authors: SCHWARTZENTRUBER DJ HOM SS DADMARZ R WHITE DE YANNELLI JR STEINBERG SM ROSENBERG SA TOPALIAN SL
Citation: Dj. Schwartzentruber et al., IN-VITRO PREDICTORS OF THERAPEUTIC RESPONSE IN MELANOMA PATIENTS RECEIVING TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2, Journal of clinical oncology, 12(7), 1994, pp. 1475-1483
RENAL DYSFUNCTION ASSOCIATED WITH THE ADMINISTRATION OF HIGH-DOSE INTERLEUKIN-2 IN 199 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CARCINOMA
Authors: GULERIA AS YANG JC TOPALIAN SL WEBER JS PARKINSON DR MACFARLANE MP WHITE RL STEINBERG SM WHITE DE EINHORN JH SEIPP CA AUSTIN HA ROSENBERG SA SCHWARTZENTRUBER DJ
Citation: As. Guleria et al., RENAL DYSFUNCTION ASSOCIATED WITH THE ADMINISTRATION OF HIGH-DOSE INTERLEUKIN-2 IN 199 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CARCINOMA, Journal of clinical oncology, 12(12), 1994, pp. 2714-2722
RECOGNITION OF NEUROECTODERMAL TUMORS BY MELANOMA-SPECIFIC CYTOTOXIC T-LYMPHOCYTES - EVIDENCE FOR ANTIGEN SHARING BY TUMORS DERIVED FROM THE NEURAL CREST
Authors: SHAMAMIAN P MANCINI M KAWAKAMI Y RESTIFO NP ROSENBERG SA TOPALIAN SL
Citation: P. Shamamian et al., RECOGNITION OF NEUROECTODERMAL TUMORS BY MELANOMA-SPECIFIC CYTOTOXIC T-LYMPHOCYTES - EVIDENCE FOR ANTIGEN SHARING BY TUMORS DERIVED FROM THE NEURAL CREST, Cancer immunology and immunotherapy, 39(2), 1994, pp. 73-83
TREATMENT OF 283 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CANCER USING HIGH-DOSE BOLUS INTERLEUKIN-2
Authors: ROSENBERG SA YANG JC TOPALIAN SL SCHWARTZENTRUBER DJ WEBER JS PARKINSON DR SEIPP CA EINHORN JH WHITE DE
Citation: Sa. Rosenberg et al., TREATMENT OF 283 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CANCER USING HIGH-DOSE BOLUS INTERLEUKIN-2, JAMA, the journal of the American Medical Association, 271(12), 1994, pp. 907-913
CLONING OF THE GENE CODING FOR A SHARED HUMAN-MELANOMA ANTIGEN RECOGNIZED BY AUTOLOGOUS T-CELLS INFILTRATING INTO TUMOR
Authors: KAWAKAMI Y ELIYAHU S DELGADO CH ROBBINS PF RIVOLTINI L TOPALIAN SL MIKI T ROSENBERG SA
Citation: Y. Kawakami et al., CLONING OF THE GENE CODING FOR A SHARED HUMAN-MELANOMA ANTIGEN RECOGNIZED BY AUTOLOGOUS T-CELLS INFILTRATING INTO TUMOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 3515-3519
HUMAN CD4-CELLS SPECIFICALLY RECOGNIZE A SHARED MELANOMA-ASSOCIATED ANTIGEN ENCODED BY THE TYROSINASE GENE( T)
Authors: TOPALIAN SL RIVOLTINI L MANCINI M MARKUS NR ROBBINS PF KAWAKAMI Y ROSENBERG SA
Citation: Sl. Topalian et al., HUMAN CD4-CELLS SPECIFICALLY RECOGNIZE A SHARED MELANOMA-ASSOCIATED ANTIGEN ENCODED BY THE TYROSINASE GENE( T), Proceedings of the National Academy of Sciences of the United Statesof America, 91(20), 1994, pp. 9461-9465
MELANOMA-SPECIFIC CD4-LYMPHOCYTES RECOGNIZE HUMAN-MELANOMA ANTIGENS PROCESSED AND PRESENTED BY EPSTEIN-BARR VIRUS-TRANSFORMED B-CELLS( T)
Authors: TOPALIAN SL RIVOLTINI L MANCINI M NG J HARTZMAN RJ ROSENBERG SA
Citation: Sl. Topalian et al., MELANOMA-SPECIFIC CD4-LYMPHOCYTES RECOGNIZE HUMAN-MELANOMA ANTIGENS PROCESSED AND PRESENTED BY EPSTEIN-BARR VIRUS-TRANSFORMED B-CELLS( T), International journal of cancer, 58(1), 1994, pp. 69-79
T-CELL RECOGNITION OF HUMAN-MELANOMA ANTIGENS
Authors: KAWAKAMI Y NISHIMURA MI RESTIFO NP TOPALIAN SL ONEIL BH SHILYANSKY J YANNELLI JR ROSENBERG SA
Citation: Y. Kawakami et al., T-CELL RECOGNITION OF HUMAN-MELANOMA ANTIGENS, Journal of immunotherapy with emphasis on tumor immunology, 14(2), 1993, pp. 88-93
HEMODYNAMIC-EFFECTS OF THE ADMINISTRATION OF TUMOR-INFILTRATING LYMPHOCYTES TO CANCER-PATIENTS
Authors: MARINCOLA FM BALKISSOON J SCHWARTZENTRUBER DJ HOM SS CONCEPCION R MARCUS SG YANNELLI J TOPALIAN SL PARKINSON DR ROSENBERG SA
Citation: Fm. Marincola et al., HEMODYNAMIC-EFFECTS OF THE ADMINISTRATION OF TUMOR-INFILTRATING LYMPHOCYTES TO CANCER-PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 13(4), 1993, pp. 282-288
TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM SELECT B-CELL LYMPHOMAS SECRETE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND TUMOR-NECROSIS-FACTOR-ALPHA IN RESPONSE TO AUTOLOGOUS TUMOR-STIMULATION
Authors: SCHWARTZENTRUBER DJ STETLERSTEVENSON M ROSENBERG SA TOPALIAN SL
Citation: Dj. Schwartzentruber et al., TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM SELECT B-CELL LYMPHOMAS SECRETE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND TUMOR-NECROSIS-FACTOR-ALPHA IN RESPONSE TO AUTOLOGOUS TUMOR-STIMULATION, Blood, 82(4), 1993, pp. 1204-1211
Risultati: 1-25 | 26-26